Explore high-purity bioactive ingredients, food additives, and nutritional raw materials validated by HPLC, UV, and monograph standardizations for seamless formulations.
A comprehensive examination of strain taxonomy, biological functionality, thermal resilience, and technological viability for next-generation functional foods and dietary additives.
Formerly classified as Lactobacillus reuteri, the reclassified Limosilactobacillus reuteri is an obligate heterofermentative Gram-positive rod-shaped bacterium. Operating within the human gastrointestinal and urogenital microbiomes, its technological value stems from the unique enzymatic breakdown of glycerol into 3-hydroxypropionaldehyde (3-HPA), commercially known as reuterin—a potent, broad-spectrum natural antimicrobial active across broad food pH profiles.
Our manufacturing facility applies high-cell-density submerged fermentation systems utilizing animal-free vegetable peptones, autolyzed non-GMO yeast extract, and automated carbohydrate metering. Cells are harvested at mid-logarithmic viability and preserved through deep eutectic freeze-drying with multisaccharide cryoprotectants, achieving cell viability benchmarks of ≥2.0×10¹¹ CFU/g.
For demanding food additive environments—including bakery matrices, thermal beverage blends, and acidic liquid foods—our industrial spray-granulated and lipid-matrix microencapsulation shields bacteria against shear forces, elevated processing temperatures (up to 75°C for brief durations), and hostile gastric acid dissolution (pH 1.8–2.2).
| Specification Parameter | Food Additive Standard (FCC Grade) | Pharma / High-Potency Grade | Standard Analytical Release Protocol |
|---|---|---|---|
| Viable Cell Count (CFU/g) | ≥ 1.0 × 10¹¹ CFU/g (100 Billion) | ≥ 2.0 × 10¹¹ to 5.0 × 10¹¹ CFU/g | ISO 7889 / IDF 117 / Plate Count on MRS Agar |
| Physical Morphology | Off-white to light yellowish, uniform free-flowing fine powder | Pure off-white crystalline micro-granules | Visual / Automated Optical Microscopy |
| Moisture Content (Karl Fischer) | ≤ 5.0% | ≤ 3.0% | USP <921> Method I (Direct Titration) |
| Water Activity (aw) | ≤ 0.15 aw (Targeted for 24-month stability) | ≤ 0.12 aw | Chilled Mirror Dew Point Method (25°C) |
| Heavy Metals (Pb, As, Cd, Hg) | Pb < 0.5 ppm, As < 0.5 ppm, Cd < 0.2 ppm, Hg < 0.1 ppm | Total Heavy Metals < 5 ppm; Pharma Compliance | ICP-MS (Inductively Coupled Plasma Mass Spectrometry) |
| Microbiological Bioburden | Non-Lactic < 1,000 CFU/g; Yeasts & Molds < 50 CFU/g | Coliforms: Negative/10g; Pathogens: Negative/25g | AOAC Official Methods / USP Microbiological Examination |
Combining world-class biotechnology, state-of-the-art bioreactor clusters, and extensive raw materials infrastructure directly from Shaanxi ShineHerb Biotech Co., Ltd.
Situated within Xi'an Hi-Tech Zone, our primary plant leverages advanced 50,000-liter sterile stainless-steel fermenters equipped with continuous optical density monitoring, precise dissolved oxygen tracking, and in-line CIP/SIP sanitation systems designed to eliminate foreign bacterial cross-contamination.
With more than 20 years of active leadership in raw ingredients, our upstream supply integration guarantees zero reliance on high-risk, volatile third parties. Every carbohydrate source, nitrogen carrier, and cryoprotective blend meets food-grade monograph purity before entering our seed tanks.
China's comprehensive manufacturing ecosystem enables tier-one pricing without cutting corners on QA. We deploy cold-chain pharmaceutical insulated packaging, dry ice expedited air freight, and refrigerated temperature-datalogger sea transport to ensure cell survival rates upon global destination arrival.
Ensuring your regulatory dossiers satisfy EFSA, US FDA GRAS, Health Canada, and Southeast Asian frameworks smoothly with comprehensive batch-specific release paperwork.
For US and Canadian food and dietary supplement manufacturers, our technical files substantiate L. reuteri safety via Qualified Presumption of Safety (QPS) dossiers and self-affirmed GRAS notifications. Complete batch documentation covers absence of antibiotic resistance transmissible plasmids via whole-genome sequencing (WGS).
EU regulatory requirements dictate meticulous microbiological identity down to the strain specific genome. ShineHerb provides genetic fingerprinting (16S rRNA gene sequencing and pulsed-field gel electrophoresis), certifying our Limosilactobacillus reuteri strains comply with EFSA requirements for novel foods and clean-label nutritional additives.
Meeting dietary requirements in the Middle East, Southeast Asia (MUI/JAKIM compliance), and global Jewish communities. Our plant maintains dedicated non-porcine, alcohol-free processing equipment with periodic third-party rabbinical and Islamic supervisory audits.
Engineered to withstand physical matrix stress, maintain viability through extended shelf-life, and maintain sensory neutrality across multiple consumer food sectors.
In yogurts, oat milks, and artisanal kefir formulations, L. reuteri operates harmoniously alongside classical starter cultures (Lactobacillus bulgaricus and Streptococcus thermophilus). It promotes smooth acidification kinetics without imparting unwanted secondary astringency or off-notes.
Pectin and gelatin-based functional gummies represent rapid market expansion. Utilizing microencapsulated Limosilactobacillus reuteri allows manufacturers to dose during low-temperature setting windows (55°C–60°C), preserving guaranteed CFU counts through standard ambient supermarket shelf-life conditions.
Free-flowing lyophilized powders blend uniformly into infant formulas, sports meal replacements, and daily synbiotic powdered drinks. Low water activity (aw < 0.15) prevents premature bacterial wakefulness in high-speed vertical form fill seal (VFFS) packing lines.
High mechanical resistance against compression pressures during rotary tableting ensures that formulations containing microcrystalline cellulose, magnesium stearate, and bioactive extracts retain minimum target colony counts without excessive overages.
Market analysis of the global probiotic and microbial food additives sector, highlighting key drivers reshaping multinational supply contract negotiations through 2030.
Global consumer demand has moved past generic multi-strain formulations toward validated, single-strain efficacy. Procurement teams actively source Limosilactobacillus reuteri due to extensive clinical substantiation targeting infantile colic alleviation, bone density retention in postmenopausal women, oral periodontal equilibrium, and cardiac lipid profile modulation.
Multinational food conglomerates no longer rely exclusively on single Western microbial laboratories. Enterprise procurement strategies now mandate dual-sourcing partnerships with established, certified Chinese manufacturing facilities able to guarantee 100-ton capacity resilience, price predictability, and uninterrupted supply continuities.
Modern consumers scrutinize excipient lists. Factory trends demand clean-label certification: fermentation media formulated without soy, milk derivatives, synthetic preservatives, or silicon dioxide carriers. ShineHerb fulfills this via organic acacia fiber and maltodextrin carriers to satisfy strict market labeling protocols.
In-depth insights designed to address technical inquiries raised by purchasing teams, QA directors, and formulation chemists before pilot and commercial sourcing.
Every commercial production batch undergoes definitive identification via 16S rRNA gene sequencing, PCR amplification, and whole-genome sequencing (WGS) to rule out genetic drift. Viable counts are quantified in accordance with ISO 7889 / IDF 117 standards on customized MRS medium under strict anaerobic conditions (37°C, 48-72 hours). Impurity profiles, extraneous bacteria, yeasts, and molds are monitored to meet international pharmacopeial limits.
For standard bulk shipments in factory-sealed double-polyethylene bags within multi-layer aluminum vacuum barrier drums, storage at -18°C or below guarantees stability for 24 months from the production date. If maintained at refrigerated temperatures (2°C to 8°C), stability is confirmed for up to 12 months. Keep exposure to ambient humidity minimal during dispensing.
Yes. As an original equipment manufacturer (OEM) and primary synthesizer, we support tailored carrier systems including pharmaceutical maltodextrin, organic inulin, resistant dextrin, or specialized lipid/protein shells for microencapsulation. Batch activity can be calibrated from 1.0×10¹⁰ CFU/g up to concentrated forms exceeding 5.0×10¹¹ CFU/g.
Each commercial release includes a lot-specific Certificate of Analysis (COA), Technical Data Sheet (TDS), Safety Data Sheet (MSDS/SDS), Flow Chart of Manufacture, Statement of Non-GMO, BSE/TSE-Free Certificate, Allergen Statement, and copies of our ISO 9001, HACCP, GMP, HALAL, and KOSHER factory registrations.
Standard sample kits (50g to 100g) are available for verified commercial buyers within 3 to 5 business days via cold-pack express courier. For custom production batches, our commercial MOQ starts at 1 kg for trial runs and 25 kg (one standard fiber drum) for regular production allocations.
We deploy insulated pharmaceutical cold boxes packed with dry ice or phase-change thermal gel packs for expedited air shipping (DHL/FedEx/air freight). For ocean shipments, we book dedicated reefer containers set at -20°C with automated electronic temperature data-loggers that record hourly readings from factory gate to unloading dock.
Explore additional high-grade raw ingredients and chemical intermediates manufactured under ISO and GMP standards for dietary supplement and specialty manufacturing.